These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31912373)

  • 41. Simultaneous upper and lower endoscopic biopsy in the diagnosis of intestinal graft-versus-host disease.
    Roy J; Snover D; Weisdorf S; Mulvahill A; Filipovich A; Weisdorf D
    Transplantation; 1991 Mar; 51(3):642-6. PubMed ID: 2006521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness.
    Mohty M; Holler E; Jagasia M; Jenq R; Malard F; Martin P; Socié G; Zeiser R
    Blood; 2020 Oct; 136(17):1903-1906. PubMed ID: 32756949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy.
    Cho BS; Yahng SA; Kim JH; Yoon JH; Shin SH; Lee SE; Choi SM; Lee DG; Eom KS; Park G; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
    Ann Hematol; 2013 Apr; 92(4):497-504. PubMed ID: 23180439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation.
    Gao L; Liu J; Zhang Y; Chen X; Gao L; Zhang C; Liu Y; Kong P; Zhong J; Sun A; Du X; Su Y; Li H; Liu H; Peng X; Zhang X
    Leuk Res; 2017 Jun; 57():27-36. PubMed ID: 28273549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.
    Major-Monfried H; Renteria AS; Pawarode A; Reddy P; Ayuk F; Holler E; Efebera YA; Hogan WJ; Wölfl M; Qayed M; Hexner EO; Wudhikarn K; Ordemann R; Young R; Shah J; Hartwell MJ; Chaudhry MS; Aziz M; Etra A; Yanik GA; Kröger N; Weber D; Chen YB; Nakamura R; Rösler W; Kitko CL; Harris AC; Pulsipher M; Reshef R; Kowalyk S; Morales G; Torres I; Özbek U; Ferrara JLM; Levine JE
    Blood; 2018 Jun; 131(25):2846-2855. PubMed ID: 29545329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substitution of methotrexate with corticosteroid for acute graft-versus-host disease prevention in transplanted patients who develop methotrexate toxicity.
    Kim SY; Kim AR; Yoon SY; Cho YH; Lee MH
    Ann Hematol; 2016 Feb; 95(3):483-91. PubMed ID: 26658911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality.
    Fuji S; Inoue Y; Utsunomiya A; Moriuchi Y; Uchimaru K; Choi I; Otsuka E; Henzan H; Kato K; Tomoyose T; Yamamoto H; Kurosawa S; Matsuoka K; Yamaguchi T; Fukuda T
    J Clin Oncol; 2016 Oct; 34(28):3426-33. PubMed ID: 27507878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between acute graft versus host disease and lung injury after allogeneic haematopoietic stem cell transplantation.
    Liu QF; Luo XD; Ning J; Xu D; Fan ZP; Sun J; Zhang Y; Xu B; Wei YQ
    Hematology; 2009 Apr; 14(2):63-72. PubMed ID: 19298716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation.
    Yamada-Fujiwara M; Miyamura K; Fujiwara T; Tohmiya Y; Endo K; Onishi Y; Ishizawa K; Kameoka J; Ito M; Harigae H
    Tohoku J Exp Med; 2012 May; 227(1):31-7. PubMed ID: 22531159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colonoscopy in the diagnosis of intestinal graft versus host disease and cytomegalovirus enteritis following allogeneic haematopoietic stem cell transplantation.
    He JD; Liu YL; Wang ZF; Liu DH; Chen H; Chen YH
    Chin Med J (Engl); 2008 Jul; 121(14):1285-9. PubMed ID: 18713549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Updated experience with inolimomab as treatment for corticosteroid-refractory acute graft-versus-host disease.
    García-Cadenas I; Valcárcel D; Martino R; Piñana JL; Novelli S; Esquirol A; Garrido A; Moreno ME; Granell M; Moreno C; Saavedra S; Briones J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):435-9. PubMed ID: 23178634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
    Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation.
    Kwon M; Bailén R; Pascual-Cascón MJ; Gallardo-Morillo AI; García Sola A; Balsalobre P; Solán L; Dorado N; Muñoz C; Serrano D; Martínez-Laperche C; Buño I; Anguita J; Díez-Martin JL
    Blood Adv; 2019 Nov; 3(21):3351-3359. PubMed ID: 31698447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.
    Naymagon S; Naymagon L; Wong SY; Ko HM; Renteria A; Levine J; Colombel JF; Ferrara J
    Nat Rev Gastroenterol Hepatol; 2017 Dec; 14(12):711-726. PubMed ID: 28951581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q; Dong M; Wang QM; Wen JY; Wu XY
    Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
    Murashige N; Kami M; Mori S; Katayama Y; Kobayashi K; Onishi Y; Hori A; Kishi Y; Hamaki T; Tajima K; Kanda Y; Tanosaki R; Takaue Y
    Am J Hematol; 2008 Aug; 83(8):630-4. PubMed ID: 18454459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NK cell predicts the severity of acute graft-versus-host disease in patients after allogeneic stem cell transplantation using antithymocyte globulin (ATG) in pretreatment scheme.
    Zhang P; Yang S; Zou Y; Yan X; Wu H; Zhou M; Sun YC; Zhang Y; Zhu H; Xu K; Wang Y; Sheng LX; Mu Q; Sun L; Ouyang G
    BMC Immunol; 2019 Dec; 20(1):46. PubMed ID: 31818250
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.
    Levine JE; Braun TM; Harris AC; Holler E; Taylor A; Miller H; Magenau J; Weisdorf DJ; Ho VT; Bolaños-Meade J; Alousi AM; Ferrara JL;
    Lancet Haematol; 2015 Jan; 2(1):e21-9. PubMed ID: 26687425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.
    Bleakley M; Heimfeld S; Loeb KR; Jones LA; Chaney C; Seropian S; Gooley TA; Sommermeyer F; Riddell SR; Shlomchik WD
    J Clin Invest; 2015 Jul; 125(7):2677-89. PubMed ID: 26053664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.
    Kennedy GA; Varelias A; Vuckovic S; Le Texier L; Gartlan KH; Zhang P; Thomas G; Anderson L; Boyle G; Cloonan N; Leach J; Sturgeon E; Avery J; Olver SD; Lor M; Misra AK; Hutchins C; Morton AJ; Durrant ST; Subramoniapillai E; Butler JP; Curley CI; MacDonald KPA; Tey SK; Hill GR
    Lancet Oncol; 2014 Dec; 15(13):1451-1459. PubMed ID: 25456364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.